Your browser doesn't support javascript.
loading
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.
Hardy-Werbin, Max; Rocha, Pedro; Arpi, Oriol; Taus, Álvaro; Nonell, Lara; Durán, Xavier; Villanueva, Xavier; Joseph-Pietras, Deborah; Nolan, Luke; Danson, Sarah; Griffiths, Richard; Lopez-Botet, Miguel; Rovira, Ana; Albanell, Joan; Ottensmeier, Christian; Arriola, Edurne.
Afiliación
  • Hardy-Werbin M; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Rocha P; Universitat de Barcelona, Barcelona, Spain.
  • Arpi O; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Taus Á; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Nonell L; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Durán X; Microarrays analysis service, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Villanueva X; Statistics department, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Joseph-Pietras D; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Nolan L; NIHR Experimental Cancer Medicine Centre, Southampton, UK.
  • Danson S; Medical Oncology Department, University Hospital Southampton, Southampton, UK.
  • Griffiths R; Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, UK.
  • Lopez-Botet M; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
  • Rovira A; Immunology unit, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Albanell J; Universitat Pompeu Fabra, Barcelona, Spain.
  • Ottensmeier C; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Arriola E; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
Oncoimmunology ; 8(6): e1593810, 2019.
Article en En | MEDLINE | ID: mdl-31069160

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncoimmunology Año: 2019 Tipo del documento: Article